Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
<i>Lactobacillus brevis</i> Alleviates DSS-Induced Colitis by Reprograming Intestinal Microbiota and Influencing Serum Metabolome in Murine Model. ✅
Go to Publication ✅
Frontiers in physiology (Front Physiol ) Vol: 10 Issue Pages: 1152 Pub: 2019 Epub: 2019 Sep 18 Authors Ding S , Ma Y , Liu G , Yan W , Jiang H , Fang J , |
|
|
The effect of Lactobacillus brevis KB290 against irritable bowel syndrome: a placebo-controlled double-blind crossover trial. ✅
Go to Publication ✅
BioPsychoSocial medicine (Biopsychosoc Med ) Vol: 6 Issue 1 Pages: 16 Pub: 2012 Aug 3 Epub: 2012 Aug 3 Authors Murakami K , Habukawa C , Nobuta Y , Moriguchi N , Takemura T , |
|
|
A Novel Lactobacillus brevis Fermented with a Vegetable Substrate (AL0035) Counteracts TNBS-Induced Colitis by Modulating the Gut Microbiota Composition and Intestinal Barrier. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 7 Pages: Pub: 2024 Mar 24 Epub: 2024 Mar 24 Authors Vesci L , Tundo G , Soldi S , Galletti S , Stoppoloni D , Bernardini R , Modolea AB , Luberto L , Marra E , Giorgi F , Marini S , |
|
|
A Novel Lactobacillus brevis Fermented with a Vegetable Substrate (AL0035) Counteracts TNBS-Induced Colitis by Modulating the Gut Microbiota Composition and Intestinal Barrier. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 7 Pages: Pub: 2024 Mar 24 Epub: 2024 Mar 24 Authors Vesci L , Tundo G , Soldi S , Galletti S , Stoppoloni D , Bernardini R , Modolea AB , Luberto L , Marra E , Giorgi F , Marini S , |
|
|
A Novel Lactobacillus brevis Fermented with a Vegetable Substrate (AL0035) Counteracts TNBS-Induced Colitis by Modulating the Gut Microbiota Composition and Intestinal Barrier. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 7 Pages: Pub: 2024 Mar 24 Epub: 2024 Mar 24 Authors Vesci L , Tundo G , Soldi S , Galletti S , Stoppoloni D , Bernardini R , Modolea AB , Luberto L , Marra E , Giorgi F , Marini S , |
|
|
A Novel Lactobacillus brevis Fermented with a Vegetable Substrate (AL0035) Counteracts TNBS-Induced Colitis by Modulating the Gut Microbiota Composition and Intestinal Barrier. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 7 Pages: Pub: 2024 Mar 24 Epub: 2024 Mar 24 Authors Vesci L , Tundo G , Soldi S , Galletti S , Stoppoloni D , Bernardini R , Modolea AB , Luberto L , Marra E , Giorgi F , Marini S , |
|
|
A Novel Lactobacillus brevis Fermented with a Vegetable Substrate (AL0035) Counteracts TNBS-Induced Colitis by Modulating the Gut Microbiota Composition and Intestinal Barrier. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 7 Pages: Pub: 2024 Mar 24 Epub: 2024 Mar 24 Authors Vesci L , Tundo G , Soldi S , Galletti S , Stoppoloni D , Bernardini R , Modolea AB , Luberto L , Marra E , Giorgi F , Marini S , |
|
|
A Novel Lactobacillus brevis Fermented with a Vegetable Substrate (AL0035) Counteracts TNBS-Induced Colitis by Modulating the Gut Microbiota Composition and Intestinal Barrier. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 7 Pages: Pub: 2024 Mar 24 Epub: 2024 Mar 24 Authors Vesci L , Tundo G , Soldi S , Galletti S , Stoppoloni D , Bernardini R , Modolea AB , Luberto L , Marra E , Giorgi F , Marini S , |
|
|
Probiotic interventions with highly acid-tolerant Levilactobacillus brevis strains improve lipid metabolism and gut microbial balance in obese mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 16 Issue 1 Pages: 112-132 Pub: 2025 Jan 2 Epub: 2025 Jan 2 Authors Zhou L , Gong L , Liu Z , Xiang J , Ren C , Xu Y , |
|
|
Probiotic interventions with highly acid-tolerant Levilactobacillus brevis strains improve lipid metabolism and gut microbial balance in obese mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 16 Issue 1 Pages: 112-132 Pub: 2025 Jan 2 Epub: 2025 Jan 2 Authors Zhou L , Gong L , Liu Z , Xiang J , Ren C , Xu Y , |
|
|
Probiotic interventions with highly acid-tolerant Levilactobacillus brevis strains improve lipid metabolism and gut microbial balance in obese mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 16 Issue 1 Pages: 112-132 Pub: 2025 Jan 2 Epub: 2025 Jan 2 Authors Zhou L , Gong L , Liu Z , Xiang J , Ren C , Xu Y , |
|
|
Exopolysaccharide of Levilactobacillus brevis M-10 Improved Physiological and Biochemical Indicators and Gut Microbiota in DSS-Induced Colitis Mice. ✅
Go to Publication ✅
Current microbiology (Curr Microbiol ) Vol: 82 Issue 5 Pages: 204 Pub: 2025 Mar 24 Epub: 2025 Mar 24 Authors Wang Q , Zhang W , Liu J , Qin W , Cai J , |
|
|
Exopolysaccharide of Levilactobacillus brevis M-10 Improved Physiological and Biochemical Indicators and Gut Microbiota in DSS-Induced Colitis Mice. ✅
Go to Publication ✅
Current microbiology (Curr Microbiol ) Vol: 82 Issue 5 Pages: 204 Pub: 2025 Mar 24 Epub: 2025 Mar 24 Authors Wang Q , Zhang W , Liu J , Qin W , Cai J , |
|
|
Exopolysaccharide of Levilactobacillus brevis M-10 Improved Physiological and Biochemical Indicators and Gut Microbiota in DSS-Induced Colitis Mice. ✅
Go to Publication ✅
Current microbiology (Curr Microbiol ) Vol: 82 Issue 5 Pages: 204 Pub: 2025 Mar 24 Epub: 2025 Mar 24 Authors Wang Q , Zhang W , Liu J , Qin W , Cai J , |
|
|
Exopolysaccharide of Levilactobacillus brevis M-10 Improved Physiological and Biochemical Indicators and Gut Microbiota in DSS-Induced Colitis Mice. ✅
Go to Publication ✅
Current microbiology (Curr Microbiol ) Vol: 82 Issue 5 Pages: 204 Pub: 2025 Mar 24 Epub: 2025 Mar 24 Authors Wang Q , Zhang W , Liu J , Qin W , Cai J , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
